Abstract
1 Three injections of cannabis extract (500 mg/kg s.c. given over 3 or 5 days) diminished thymus gland weight but not the weights of spleen or liver in weanling female and adult male mice kept at room temperature.
2 Both cannabis extract (500 mg/kg s.c.) and Δ1-tetrahydrocannabinol (Δ1-THC; 10 and 20 mg/kg i.p.) elevated corticosterone levels in mouse plasma.
3 A pretreatment that consisted of three daily subcutaneous injections of 500 mg/kg of cannabis extract and that was shown to produce tolerance to the `cataleptic' effect of Δ1-THC (2 mg/kg i.v.) in mice, also produced tolerance to the effect of Δ1-THC (10 mg/kg i.p.) on corticosterone levels in mouse plasma. However, this pretreatment did not reduce the rise in plasma corticosterone concentration produced by immobilization.
4 Tolerance to the effect of Δ1-THC (10 mg/kg i.p.) on corticosterone levels in mouse plasma was also produced by the pretreatment of mice with a single injection of Δ1-THC (10 mg/kg s.c.). Three daily injections of Δ1-THC (10 or 30 mg/kg s.c.) also produced tolerance.
5 In a thermoneutral environment (30-32° C) in which cannabis extract does not produce hypothermia, the drug no longer reduced thymus gland weight. However the effect of cannabis extract and of Δ1-THC on corticosterone plasma levels was the same at room temperature as at 30-32° C. Tolerance to the latter effect of Δ1-THC was also produced equally readily under the two conditions.
6 It is concluded that pretreatment with cannabis extract or Δ1-THC can produce tolerance to the effect of Δ1-THC on corticosterone levels in mouse plasma and does so without impairing the effect of immobilization stress on corticosterone release. In addition, both the rise in corticosterone plasma levels produced by cannabis or Δ1-THC and the development of tolerance to this effect can still take place in the absence of hypothermia.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- DOUGHERTY T. F. Effect of hormones on lympatic tissue. Physiol Rev. 1952 Oct;32(4):379–401. doi: 10.1152/physrev.1952.32.4.379. [DOI] [PubMed] [Google Scholar]
- Dewey W. L., Peng T. C., Harris L. S. The effect of 1-trans-delta 9-tetrahydrocannabinol on the hypothalamo-hypophyseal-adrenal axis of rats. Eur J Pharmacol. 1970;12(3):382–384. doi: 10.1016/0014-2999(70)90094-4. [DOI] [PubMed] [Google Scholar]
- Drew W. G., Slagel D. E. Delta 9-THC: selective impairment of corticosterone uptake by limbic structures of the rat. Neuropharmacology. 1973 Sep;12(9):909–914. doi: 10.1016/0028-3908(73)90043-9. [DOI] [PubMed] [Google Scholar]
- GUILLEMIN R., CLAYTON G. W., SMITH J. D., LIPSCOMB H. S. Measurement of free corticosteroids in rat plasma: physiological validation of a method. Endocrinology. 1958 Sep;63(3):349–358. doi: 10.1210/endo-63-3-349. [DOI] [PubMed] [Google Scholar]
- HALBERG F., PETERSON R. E., SILBER R. H. Phase relations of 24-hour periodicities in blood corticosterone, mitoses in cortical adrenal parenchyma, and total body activity. Endocrinology. 1959 Feb;64(2):222–230. doi: 10.1210/endo-64-2-222. [DOI] [PubMed] [Google Scholar]
- Holtzman D., Lovell R. A., Jaffe J. H., Freedman D. X. 1-delta9-tetrahydrocannabinol: neurochemical and behavioral effects in the mouse. Science. 1969 Mar 28;163(3874):1464–1467. doi: 10.1126/science.163.3874.1464. [DOI] [PubMed] [Google Scholar]
- Kubena R. K., Perhach J. L., Jr, Barry H., 3rd Corticosterone elevation mediated centrally by delta 1-tetrahydrocannabinol in rats. Eur J Pharmacol. 1971;14(1):89–92. doi: 10.1016/0014-2999(71)90128-2. [DOI] [PubMed] [Google Scholar]
- Paton W. D., Pertwee R. G. Effect of cannabis and certain of its constituents on pentobarbitone sleeping time and phenazone metabolism. Br J Pharmacol. 1972 Feb;44(2):250–261. [PMC free article] [PubMed] [Google Scholar]
- Silber R. H. Fluorimetric analysis of corticoids. Methods Biochem Anal. 1966;14:63–78. doi: 10.1002/9780470110324.ch3. [DOI] [PubMed] [Google Scholar]
- Sofia R. D., Nalepa S. D., Harakal J. J., Vassar H. B. Anti-edema and analgesic properties of delta9-tetrahydrocannabinol (THC). J Pharmacol Exp Ther. 1973 Sep;186(3):646–655. [PubMed] [Google Scholar]